Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease

被引:13
|
作者
Mao, Xianqing
Ait-Aissa, Karima
Lagrange, Jeremy
Youcef, Gina
Louis, Huguette [1 ]
机构
[1] INSERM, Fac Med, U961, F-54500 Vandoeuvre Les Nancy, France
关键词
Hypertension; hypercoagulability; metabolic syndrome; animal model; ACTIVATOR INHIBITOR TYPE-1; BLOOD-PRESSURE; ANGIOTENSIN-II; INSULIN-RESISTANCE; AT(1) RECEPTOR; ADIPOSE-TISSUE; ANIMAL-MODEL; ARTERIAL THROMBOSIS; OXIDATIVE STRESS; GENE-EXPRESSION;
D O I
10.3233/BME-2012-0688
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cardiovascular disease (CVD) is one of the main causes of mortality in the world representing around 30% of all deaths. It constitutes also an important factor in morbidity and incapacity. There are several related CVD risk factors such as hypertension, metabolic syndrome (MetS) and hypercoagulability. The exact mechanisms that underlie the relation between those factors and CVD are not sufficiently known yet; pathogenic explanations are lacking also for the mechanisms relating metabolic factors to insulin resistance (IR) and the association with the development of atherosclerosis and thrombosis. The possible links between hypertension, hemostasis alterations and MetS are examined in this report.
引用
收藏
页码:35 / 48
页数:14
相关论文
共 50 条
  • [31] Shiftwork and metabolic risk factors of cardiovascular disease
    Ha, M
    Park, J
    JOURNAL OF OCCUPATIONAL HEALTH, 2005, 47 (02) : 89 - 95
  • [32] Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy, and Risk of Cardiovascular Disease in Hypertension
    Iwashima, Yoshio
    Horio, Takeshi
    Kamide, Kei
    Tokudome, Takeshi
    Yoshihara, Fumiki
    Nakamura, Satoko
    Ogihara, Toshio
    Rakugi, Hiromi
    Kawano, Yuhei
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (03) : 290 - 298
  • [33] Metabolic syndrome and cardiovascular risk factors in the menopausal transition
    Siseles, Nestor
    Berg, Gabriela
    GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (01) : 1 - 3
  • [34] THE IMPACT OF UNCONTROLLED HYPERTENSION ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC SYNDROME
    Tsounis, D.
    Brellas, N.
    Stamos, G.
    Laschos, V.
    Voutsela, D.
    Platoyiannis, D.
    JOURNAL OF HYPERTENSION, 2010, 28 : E483 - E483
  • [35] Cardiovascular risk factors and metabolic syndrome in a French cohort
    Bauduceau, B
    Rousseau, C
    Mayaudon, H
    Baigts, F
    Burnat, P
    Dupuy, O
    Le Berre, JP
    Paillasson, S
    DIABETES, 2004, 53 : A522 - A522
  • [36] Management of metabolic syndrome and associated cardiovascular risk factors
    De Flines, J.
    Scheen, A. J.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (02) : 261 - 266
  • [37] Nontraditional cardiovascular risk factors in pediatric metabolic syndrome
    Retnakaran, R
    Zinman, B
    Connelly, PW
    Harris, SB
    Hanley, AJG
    JOURNAL OF PEDIATRICS, 2006, 148 (02): : 176 - 182
  • [38] Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women
    Nanchahal, K
    Ashton, WD
    Wood, DA
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (01) : 57 - 64
  • [39] Hypercoagulability in the metabolic syndrome
    Nieuwdorp, M
    Stroes, ESG
    Meijers, JC
    Büller, H
    CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) : 155 - 159
  • [40] The clinical significance of metabolic syndrome in hypertension: Metabolic syndrome increases cardiovascular risk: The contrary position
    Sarzani R.
    High Blood Pressure & Cardiovascular Prevention, 2008, 15 (2) : 59 - 62